IBMS/ECTS 2001 - PROGRAM and ABSTRACTS
OSTEOPOROSIS I
Thursday, June 7, 2001
11:30 - 12:30 Auditorium
The abstract text of short communications (prefix SC) can be found in the Abstracts section. Click on the Abstract number.
- 11:30 SC12 T
- EFFECT OF TRAUMA ASSESSMENT ON NONVERTEBRAL FRACTURE RISK REDUCTION IN THE RECOMBINANT HUMAN PARATHYROID (1-34) FRACTURE PREVENTION STUDY
- E. F. Eriksen*, S. L. Myers, G. A. Gaich, O. Wang, B. H. Mitlak
- Aarhus Amtssygehus, Aarhus, Denmark; Eli Lilly and Company, Indianapolis, IN, USA
- 11:35 SC13 T
- VALIDATION OF CHANGE IN BONE MINERAL DENSITY AS A SURROGATE FOR FRACTURE RISK AFTER STATISTICAL ADJUSTMENT FOR IMPRECISION IN BMD MEASUREMENTS
- N. Watts*, S. Sarkar, W. Wu, M. Wong, K. Harper
- Emory University, Atlanta, GA, USA; Eli Lilly and Company, Indianapolis, IN, USA
- 11:40 SC14 T
- PREVENTION OF OSTEOPOROTIC FRACTURES IN DUTCH MEN AND WOMEN: A COST EFFECTIVENESS EVALUATION
- C. E. De Laet*, H. A. P. Pols
- Institute for Medical Technology Assessment, Rotterdam, the Netherlands; Dept of Internal Medicine, Erasmus University Medical School, Rotterdam, the Netherlands
- 11:45 SC15 T
- DIGITAL X-RAY RADIOGRAMMETRY OF THE METACARPALS PREDICTS WRIST, HIP AND VERTEBRAL FRACTURE RISK: A PROSPECTIVE ANALYSIS FROM THE STUDY OF OSTEOPOROTIC FRACTURES
- M. L. Bouxsein*, L. Palermo, C. Yeung, D. M. Black
- Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA; Prevention Sciences Group, Dept. of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA
- 11:50 SC16 T
- SIT-TO-STAND TEST, A SIMPLE PREDICTOR OF HIP AND OTHER FRACTURES IN OLDER WOMEN
- K. Kayan*, E. V. McCloskey, R. U. Ashford, A. Dey, J. A. Kanis
- WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK
- 11:55 SC17 T
- POSITIVE ASSOCIATION BETWEEN NET ENDOGENOUS NONCARBONIC ACID PRODUCTION (NEAP) AND BONE HEALTH: FURTHER SUPPORT FOR THE IMPORTANCE OF THE SKELETON TO ACID-BASE BALANCE
- S. A. New*, H. M. Macdonald, D. A. Grubb, D. M. Reid
- University of Surrey, England, UK; University of Aberdeen, Scotland, UK; Rowett Research Institute, Scotland, UK
- 12:00 SC18 T
- LOW DOSE SUPPLEMENTATION WITH CHOLECALCIFEROL AND CALCIUM DURING WINTER TIME PREVENTS SEASON-RELATED BONE LOSS
- H. W. Woitge*, K. Witte, B. Doschko, B. Auler, A. Knothe, R. Ziegler, B. Lemmer, M. J. Seibel
- Department of Medicine I, University of Heidelberg, Heidelberg, Germany; Department of Pharmacology, University of Heidelberg, Heidelberg, Germany
- 12:05 SC19 T
- TWO YEAR RESULTS OF ONCE-WEEKLY ADMINISTRATION OF ALENDRONATE 70 MG FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
- R. Rizzoli*, C. Roux, S. Greenspan, H. Bone, T. Schnitzer, N. Watts, S. Adami, B. Uebelhart, C. Peverly, A. Santora, A. Kaur, M. Wu, J. Orloff
- Hopital Cantonal, Geneva, Switzerland; Hopital Cochin, Paris, France; University of Pittsburgh, Pittsburgh, PA, USA; Michigan Bone Clinic, Detroit, MI, USA; Northwestern U., Chicago, IL, USA; Emory University, Atlanta, GA, USA; University of Verona, Italy; Merck Research Labs, Rahway, NJ, USA
- 12:10 SC20 T
- QUANTITATIVE 3D SYNCHROTRON RADIATION MICRO-TOMOGRAPHY EVALUATION OF OSTEON MINERALIZATION DEGREE DURING ETIDRONATE TREATMENT IN OSTEOPOROTIC PATIENTS
- S. Nuzzo, F. Peyrin*, E. Martín-Badosa, G. Boivin, C. Alexandre, M. H. Lafage-Proust
- ESRF, Grenoble, France; CREATIS, UMR CNRS 5515, Villeurbanne, France; INSERM EM9901, J Monnet University, St-Etienne, France; INSERM U403, Lyon, France
- 12:15 SC21 T
- THE RECHALLENGE OF PATIENTS WHO PREVIOUSLY DISCONTINUED ALENDRONATE DUE TO UPPER GASTROINTESTINAL SYMPTOMS
- P. D. Miller*, A. A. Licata, G. Woodson, M. P. Ettinger, B. Mako, M. E. Smith, L. Wang, J. Yates, M. E. Melton, J. Palmisano
- Colorado Center for Bone Research, Lakewood, CO, USA; Cleveland Clinic Foundation, Cleveland, OH, USA; Atlanta Research Center, Decatur, GA, USA; Clinical Research Center of South Florida, Stuart, FL USA; Merck & Co., Inc., West Point, PA, USA
- 12:20 SC22 T
- MECHANISM-BASED LOCAL IRRITATION BY NITROGEN-BISPHOSPHONATES
- A. A. Reszka*, J. E. Fisher, G. A. Rodan
- Merck Research Laboratories, West Point, PA, USA
All Short Communications will be displayed as posters throughout the conference. Those presented in this session will be attended during Poster Session 2 which follows.